Vp Corporate Development
CurrentUnlocking an expansive target space to build a pipeline of novel, solid tumour targeted therapeutics
Please complete the CAPTCHA to continue
@credit-suisse.com
✓
LinkedIn matched
A concise factual answer block for searchers comparing this professional profile.
Mark Lees is listed as Biotech Corporate Development at T-Cypher Bio, based in London, England, United Kingdom. AeroLeads shows a work email signal at credit-suisse.com and a matched LinkedIn profile for Mark Lees.
Mark Lees previously worked as VP Corporate Development at T-Cypher Bio and VP Strategy and Operations at Mestag Therapeutics. Mark Lees holds Mbiochem, Biochemistry from University Of Oxford.
This section adds company-level context without repeating Mark Lees's masked contact details.
AeroLeads found 1 current-domain work email signal for Mark Lees. Compare company email patterns before reaching out.
I have broad experience in biotech company establishment, growth and development gained from leadership positions in start-ups as well as established clinical-stage companies. I have successfully operated at corporate level as well as the level of portfolios and individual programmes.I hold an undergraduate degree in Biochemistry from Oxford (MBioch), a molecular biology PhD from Imperial College London and an MBA from Oxford.
Listed skills include Software Development, Multithreading, C#, Trading Systems, and 68 others.
Company context helps verify the profile and gives searchers a useful next step.
A career timeline built from the work history available for this profile.
Oxford, England, United Kingdom
Unlocking an expansive target space to build a pipeline of novel, solid tumour targeted therapeutics
Cambridge, United Kingdom
F-Star Therapeutics are bringing unique immune oncology drugs to patients using our novel bi-specific antibody platform.
Immunocore is one of Europe’s leading biotech companies, developing a unique immune-oncology platform that harnesses the power of T-cell receptors as therapies.
London, United Kingdom
Activities and Societies: ERASMUS exchange student - Groningen, The Netherlands
My research was concerned with finding causative genes within a number of models of human systemic lupus erythematosus (SLE). I.
Quick answers generated from the profile data available on this page.
Mark Lees works for T-Cypher Bio.
Mark Lees is listed as Biotech Corporate Development at T-Cypher Bio.
AeroLeads has found 1 work email signal at @credit-suisse.com for Mark Lees at T-Cypher Bio.
Mark Lees is based in London, England, United Kingdom while working with T-Cypher Bio.
Mark Lees has worked for T-Cypher Bio, Mestag Therapeutics, F-Star Biotechnology Ltd, Immunocore Limited, and Magnus Life Science.
You can use AeroLeads to view verified contact signals for Mark Lees at T-Cypher Bio, including work email, phone, and LinkedIn data when available.
Mark Lees holds Mbiochem, Biochemistry from University Of Oxford.
Mark Lees is listed with skills including Software Development, Multithreading, C#, Trading Systems, Linux, C++, Unix, and Sql.
Search by job title, company, industry, location, and seniority. Export verified B2B contact data when you need it.
Start free trial Search contactsCheck these profiles if this is not the Mark Lees you were looking for.
View similar profiles